Sunday, April 30, 2006

Osteoporosis drug 'prevents breast cancer'

DailyMail, April 19, 2006
A drug used to treat osteoporosis also guards against breast cancer researchers have claimed.
They found Evista has fewer side effects and could reduce the risk of developing invasive breast cancer by 50 per cent. --Click the title of this post to read the full article from its source--

Gel May Replace Radiation Treatment For Breast Cancer

WPXI, April 30, 2006
Women who have surgery for breast cancer often have to undergo radiation therapy. It often causes breast deformities that then need to be corrected through reconstructive surgery. Now researchers at the McGown Institute for Regenerative Medicine at the University of Pittsburgh and bioengineers at Carnegie Mellon University may have found a way to avoid that complication from breast cancer surgery. They have developed a polymer based therapy that serves as artificial tissue filler after surgery and also delivers chemotherapy. --Click the title of this post to read the full article from its source--

Friday, April 21, 2006

LED May Prevent Skin Side Effects Caused by Radiation in Breast Cancer Patients

CancerConsultants, April 20, 2006
According to a late-breaking abstract presented at the 2006 American Society for Laser Medicine and Surgery meeting, the use of low-energy non-thermal light-emitting diode (LED) photomodulation in women with early breast cancer undergoing radiation therapy significantly reduced side effects to the skin normally associated with radiation therapy. Early breast cancer (cancer that has not spread from the breast to distant sites in the body) is often treated with surgical removal of the cancer followed by radiation therapy with or without chemotherapy or hormone therapy. --Click the title of this post to read the full article from its source--

Better Breast Prosthesis Services Needed

VHI Healthcare, April 18, 2006
Many women who have survived breast cancer are calling for improvements in prosthesis fitting services across the country. The Irish Cancer Society, through Action Breast Cancer, says 16,000 women in Ireland have undergone a mastectomy and require external breast prosthesis. They say that new findings from a survey of 500 women demand urgent action to enhance services. --Click the title of this post to read the full article from its source--

Hormone Replacement Therapy May Not Increase Breast Cancer Risk

Times & Transcript, April 19, 2006
Postmenopausal women who have had hysterectomies can safely take estrogen-alone therapy without raising their breast cancer risk, the latest analysis of data from a large but disconcerting U.S. study suggests. --Click the title of this post to read the full article from its source--

Monday, April 17, 2006

Breast ducts: A new site for cancer treatment?

Xagena.it, April 17, 2006
Researchers are studying whether delivering chemotherapy drugs directly to breast "plumbing" might make treatment of early breast cancer easier on the patient and at least as good as surgery or radiation. --Click the title of this post to read the full article from its source--

Scientists have identified how breast cancer cells might evade detection

Advertiser Adelaide, April 17, 2006
Queensland scientists have identified how breast cancer cells might evade being detected by the immune system in a breakthrough that could help develop treatments to fight a range of cancers.Researchers at the Queensland Institute of Medical Research have discovered dendritic cells might hold the clue to detection of breast cancers and could help fight them. Dendritic cells were the immune system's means of seeking out cells infected with viruses and bacteria and cells that were not functioning properly or had gone astray and could evolve into cancer. When dendritic cells noticed a change, they notified the body's defences that those cells should be eliminated. QIMR's Associate Professor Alejandro Lopez, however, said research showed breast cancers could produce factors which caused dendritic cells to die and to lose their surveillance capabilities. --Click the title of this post to read the full article from its source--

Tuesday, April 04, 2006

New way to assess breast cancer recurrence

UPI NewsTrack, April 4, 2006
Taiwan and U.S. researchers have developed a new prediction model to help physicians determine the chance of recurrence in high-risk breast cancer patients...The new method takes into account five different risk factors in determining the chance of recurrence in high-risk patients and approximating the benefits of radiation therapy..."This prediction model is important because identifying higher risk patients sooner will allow doctors to more aggressively treat those cancers, in the hopes of giving patients a higher chance for a cure." --Click the title of this post to read the full article from its source--

Monday, April 03, 2006

Study Shows Drug Blocks Breast Cancer Migration To Bone

Medical news Today, April 1, 2006
An international research team has identified what may be a critical molecule in the ability of tumours to metastasize -- or spread -- into bone. The research found that a protein in bone called RANKL appears to communicate with a receptor in breast, prostate and skin cancer cells -- telling them to migrate. Moreover, a drug already known to block RANKL's activity may prevent cancers from spreading into the bone. --Click the title of this post to read the full article from its source--

Translational Derepression & Oncogene Expression In Breast Cancer Cells

Medical News Today, April 03, 2006
Drs. Anuradha Mehta, Christopher Trotta and Stuart Peltz (PTC Therapeutics) have uncovered a novel mechanism whereby the translation efficiency of oncogenes is increased in cancer cells. The human epidermal growth factor receptor 2 (Her-2) is an established oncogene whose overexpression drives metastasis in about 25% of breast cancer patients. In the April 15th issue of Genes & Development, the researchers report that an element within the 3' untranslated region (UTR) of Her2 mRNA can inhibit translational repression by the 5' upstream open reading frame (uORF), and thereby increase Her2 translation in breast cancer cells. ----Click the title of this post to read the full article from its source--

Saturday, April 01, 2006

Researchers Find Two New Genes Predict Breast Cancer Outcomes

MedIndia, April 1, 2006
Mayo Clinic researchers have announced that two new genes found with breast tumors can predict the outcomes of the cancer with a faire degree of accuracy . In the report appearing in he April 1 issue of Clinical Cancer Research, they say that these genes could help identify women at risk for an early relapse of breast cancer. --Click the title of this post to read the full article from its source--

/* WebRing Code */